0.12
+0.0103(+8.99%)
Currency In USD
| Previous Close | 0.11 |
| Open | 0.1 |
| Day High | 0.14 |
| Day Low | 0.1 |
| 52-Week High | 6.75 |
| 52-Week Low | 0.1 |
| Volume | 2.15M |
| Average Volume | 621,407 |
| Market Cap | 1.3M |
| PE | -0.05 |
| EPS | -2.4 |
| Moving Average 50 Days | 0.17 |
| Moving Average 200 Days | 0.25 |
| Change | 0.01 |
If you invested $1000 in Aclarion, Inc. (ACON) since IPO date, it would be worth $2.87 as of December 21, 2024 at a share price of $0.125. Whereas If you bought $1000 worth of Aclarion, Inc. (ACON) shares 1 year ago, it would be worth $29.6 as of December 21, 2024 at a share price of $0.125.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash
GlobeNewswire Inc.
Nov 21, 2024 1:00 PM GMT
Article Focuses on how Leading Physicians are Incorporating Nociscan Into Their Clinical Practices for Chronic Low Back Pain Patients MAGNETOM Flash is a Peer-to-Peer Magazine Published by Siemens to Showcase Advancing Technologies in the MRI Space T
Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit
GlobeNewswire Inc.
Oct 10, 2024 11:00 AM GMT
Fireside Chat Scheduled for 2:00 PM ET on October 15, 2024 BROOMFIELD, Colo., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and p
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
GlobeNewswire Inc.
Sep 27, 2024 10:57 AM GMT
Modic Changes (MC) are MRI Findings Associated With Endplate Damage, Neoinnervation, and Chronic Low Back Pain (cLBP) MR Spectroscopy (MRS) Measurement of Intradiscal Propionic Acid (PA) can Clarify MC Etiology and Help Stratify MC Patients to Potent